MENU

SNDX Syndax Pharmaceuticals Forecast, Technical & Fundamental Analysis

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology
SNDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
SNDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SNDX is expected to report earnings to fall 15.67% to -46 cents per share on October 29

Syndax Pharmaceuticals SNDX Stock Earnings Reports
Q3'26
Est.
$-0.46
Q2'26
Missed
by $0.07
Q1'26
Beat
by $0.14
Q4'25
Missed
by $0.19
Q3'25
Beat
by $0.03
The last earnings report on August 04 showed earnings per share of -55 cents, missing the estimate of -47 cents. With 527.26K shares outstanding, the current market capitalization sits at 1.59B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals for novel cancer therapies

Industry Biotechnology

Industry
Biotechnology
Address
730 Third Avenue
Phone
+1 781 419-1400
Employees
277
Web
https://www.syndax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMF55.870.48
+0.87%
OneMain Holdings
CRWD266.091.34
+0.51%
Crowdstrike Holdings Inc
LVO2.58-0.01
-0.39%
LiveOne Inc
CNMD45.93-0.30
-0.65%
CONMED Corp
RCKT2.59-0.04
-1.52%
Rocket Pharmaceuticals

SNDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with REPL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
-3.09%
REPL - SNDX
51%
Loosely correlated
+1.59%
VCYT - SNDX
45%
Loosely correlated
-4.02%
KURA - SNDX
43%
Loosely correlated
-0.56%
RLAY - SNDX
43%
Loosely correlated
+2.44%
SMMT - SNDX
39%
Loosely correlated
-1.30%
More
Syndax Pharmaceuticals (SNDX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com